Strumento inattivo

Altre lingue Clinigen Group plc

Azioni

CLIN

GB00B89J2419

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Clinigen Launches NaviGATE an Educational Programme for Rare Disease Patients and Organizations	12/09/23
CNX Therapeutics Limited acquired Cardioxane® (dexrazoxane), Savene® (dexrazoxane), Totect® (dexrazoxane) and Ethyol®, four cancer support therapies from Clinigen Limited.	10/08/23
Clinigen Limited Reports Earnings Results for the Full Year Ended June 30, 2022	09/05/23
Adragos Pharma GmbH completed the acquisition of Lamda Laboratories S.A. from Clinigen Limited.	03/04/23
JCR Pharmaceuticals implements IZCARGO Named Patient Supply Program	28/03/23
Clinigen : Supplier Code of Conduct 2023	28/03/23
Adragos Pharma acquires Clinigen's development unit, Lamda Laboratories	20/03/23
Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories	20/03/23
Adragos Pharma GmbH signed a definitive agreement to acquire Lamda Laboratories S.A. from Clinigen Limited.	20/03/23
Clinigen : Global Human Rights & Anti Slavery Policy	10/03/23
Clinigen : Global Anti-Bribery & Corruption Policy	10/03/23
Clinigen : Global Anti-Money Laundering Policy	10/03/23
Clinigen : Global Anti-Trust Policy	10/03/23
Clinigen : Global Health & Safety Policy	10/03/23
Clinigen : Global Freedom to Speak Up Policy	10/03/23
Clinigen : Global Data Protection Policy	10/03/23
Clinigen : Global Diversity, Equity & Inclusion Policy	10/03/23
Clinigen : Global Environmental Policy	10/03/23
Clinigen : Global Human Rights & Anti Slavery Policy	03/02/23
Iovance Biotherapeutics, Inc. entered into a definitive agreement to acquire Worldwide rights of Proleukin of Clinigen Limited for approximately £210 million.	23/01/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Clinigen Group plc

Azioni

CLIN

GB00B89J2419

Altre lingue

Filtri